You are here
UN releases post-MDG agenda
5 June, 2013
The United Nations (UN) has released the long awaited report outlining the development agenda for beyond the millennium development goals (MDGs) that expire in 2015. The report was compiled by 27 high level leaders appointed by the UN Secretary General Ban Ki-moon, after consulting 500,000 people from 121 countries, following five meetings and up to 5,000 pages of submissions.
UNITAID reduce cost for paediatric HIV treatment
31 May, 2013
Negotiations by UNITAID with drug manufacturers have resulted in an 80 percent price reduction for key HIV, malaria and tuberculosis (TB) treatments for children, and a 60 percent reduction on second-line HIV treatments.
Women Deliver conference: Maternal health and HIV in Africa
29 May, 2013
Today is the start of the third 'Women Deliver' conference (May 28-30) that will see thousands of people from around the world gather in Malaysia to call for action on improving health, rights and empowerment of women and girls.
African leadership the 'magic bullet' in the fight against AIDS
28 May, 2013
UNAIDS Executive Director, Michel Sidibé, applauded the progress made in Africa, stating that leadership and shared responsibility have been the key drivers of this success. This, after the number of people on antiretroviral treatment in Africa has increased by 805 percent between 2005 and 2012, according to a new report released by UNAIDS this week.
Minimal programme and funding support for MSM in southern Africa
17 May, 2013
HIV and AIDS funding for gay men, other men who have sex with men (MSM) and transgender people in Southern Africa is grossly inadequate, according to a study published yesterday by amfAR and Johns Hopkins University.
Sex workers in Benin benefit from targeted interventions
8 May, 2013
Targeted interventions have resulted in reduced transmission of HIV and other sexually transmitted diseases (STDs), among female sex workers (FSWs) in Benin.
South Africa to overhaul drug patent laws
7 May, 2013
South Africa is planning to close loopholes in the law that allow pharmaceutical companies to retain patent rights through applying minor adjustments to drugs.
High HIV prevalence among IDU's in Libya
2 May, 2013
A recent study published in the April edition of Journal of Acquired Immune Deficiency Syndromes (JAIDS), has found a concentrated HIV epidemic among injecting drug users's (IDU's) in Libya, with 84% of IDU's admitted to the only drug-treatment centre in the country testing positive for the virus.